{"id":"https://openalex.org/W2024912346","doi":"https://doi.org/10.3790/sfo.64.4.78","title":"Rationale Gesundheitspolitik in Europa: Die Rolle der Nutzenbewertung f\u00fcr eine evidenzbasierte Arzneimittelversorgung","display_name":"Rationale Gesundheitspolitik in Europa: Die Rolle der Nutzenbewertung f\u00fcr eine evidenzbasierte Arzneimittelversorgung","publication_year":2015,"publication_date":"2015-04-01","ids":{"openalex":"https://openalex.org/W2024912346","doi":"https://doi.org/10.3790/sfo.64.4.78","mag":"2024912346"},"language":"de","primary_location":{"id":"doi:10.3790/sfo.64.4.78","doi":"https://doi.org/10.3790/sfo.64.4.78","is_oa":false,"landing_page_url":"https://doi.org/10.3790/sfo.64.4.78","pdf_url":null,"source":{"id":"https://openalex.org/S46772693","display_name":"Sozialer Fortschritt","issn_l":"0038-609X","issn":["0038-609X","1865-5386"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["jufo-1"],"host_organization":"https://openalex.org/P4310313978","host_organization_name":"Duncker & Humblot","host_organization_lineage":["https://openalex.org/P4310313978"],"host_organization_lineage_names":["Duncker & Humblot"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sozialer Fortschritt","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021524711","display_name":"Remi Maier-Rigaud","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Remi Maier-Rigaud","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5021524711"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.1054738,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"64","issue":"4","first_page":"78","last_page":"83"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.026599999517202377,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3605","display_name":"Health Information Management"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benefit-assessment","display_name":"benefit assessment","score":0.9490000009536743},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.47699999809265137},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.8650000095367432}],"concepts":[{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.6007564663887024},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.5744155049324036},{"id":"https://openalex.org/C108759981","wikidata":"https://www.wikidata.org/wiki/Q788590","display_name":"Authorization","level":2,"score":0.44804251194000244},{"id":"https://openalex.org/C178550888","wikidata":"https://www.wikidata.org/wiki/Q2043282","display_name":"Business administration","level":1,"score":0.39910680055618286},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3386824429035187},{"id":"https://openalex.org/C187736073","wikidata":"https://www.wikidata.org/wiki/Q2920921","display_name":"Management","level":1,"score":0.3327407240867615},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.15348660945892334},{"id":"https://openalex.org/C105639569","wikidata":"https://www.wikidata.org/wiki/Q582577","display_name":"Economic policy","level":1,"score":0.1275477111339569},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3790/sfo.64.4.78","doi":"https://doi.org/10.3790/sfo.64.4.78","is_oa":false,"landing_page_url":"https://doi.org/10.3790/sfo.64.4.78","pdf_url":null,"source":{"id":"https://openalex.org/S46772693","display_name":"Sozialer Fortschritt","issn_l":"0038-609X","issn":["0038-609X","1865-5386"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["jufo-1"],"host_organization":"https://openalex.org/P4310313978","host_organization_name":"Duncker & Humblot","host_organization_lineage":["https://openalex.org/P4310313978"],"host_organization_lineage_names":["Duncker & Humblot"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sozialer Fortschritt","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Industry, innovation and infrastructure","score":0.4099999964237213,"id":"https://metadata.un.org/sdg/9"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1966003263","https://openalex.org/W1993710726","https://openalex.org/W1994558672","https://openalex.org/W2059632063","https://openalex.org/W2070960668","https://openalex.org/W2079763503","https://openalex.org/W2091656459","https://openalex.org/W2155874394"],"related_works":["https://openalex.org/W3104897255","https://openalex.org/W2242892832","https://openalex.org/W2178411225","https://openalex.org/W2389137229","https://openalex.org/W3130487158","https://openalex.org/W2980164204","https://openalex.org/W2328019197","https://openalex.org/W4235478120","https://openalex.org/W2088925337","https://openalex.org/W4243372657"],"abstract_inverted_index":{"Die":[0],"Nutzenbewertung":[1,64,76],"von":[2,6,20,33],"Gesundheitstechnologien":[3],"und":[4,96],"insbesondere":[5],"Arzneimitteln":[7],"kann":[8],"einen":[9],"erheblichen":[10],"Beitrag":[11],"zu":[12],"einer":[13],"rationalen":[14],"Gesundheitspolitik":[15],"in":[16,24,108,137,145,165],"Europa":[17],"leisten.":[18],"Ausgehend":[19],"den":[21],"positiven":[22],"Erfahrungen":[23],"Deutschland,":[25],"die":[26,40,55,63,75,82,93,97],"unter":[27],"anderem":[28],"auf":[29,42,51],"der":[30,44,99],"starken":[31],"Evidenzgrundlage":[32],"klinischen":[34],"Studiendaten":[35],"aus":[36],"Marktzulassungsantr\u00e4gen":[37],"beruhen,":[38],"werden":[39],"Entwicklungen":[41],"Ebene":[43,53],"Europ\u00e4ischen":[45],"Union":[46],"analysiert:":[47],"W\u00e4hrend":[48],"klinische":[49],"Pr\u00fcfungen":[50],"europ\u00e4ischer":[52],"durch":[54],"neue":[56],"EUVerordnung":[57],"ab":[58],"2016":[59,177],"harmonisiert":[60],"werden,":[61],"wird":[62,73],"bislang":[65],"nur":[66],"freiwillig":[67],"im":[68],"HTA":[69,195],"Network":[70],"koordiniert.":[71],"Es":[72],"vorgeschlagen,":[74],"verbindlich":[77],"nach":[78],"einheitlicher":[79],"Methodik":[80],"f\u00fcr":[81,92,101],"gesamte":[83],"EU":[84,167,181],"durchzuf\u00fchren.":[85],"Hierdurch":[86],"w\u00fcrden":[87],"Ressourcen":[88],"eingespart,":[89],"transparente":[90],"Innovationsanreize":[91],"Pharmaindustrie":[94],"gesetzt":[95],"Qualit\u00e4t":[98],"Versorgung":[100],"europ\u00e4ische":[102],"Patienten":[103],"verbessert.":[104],"Rational":[105],"Health":[106],"Policy":[107],"Europe:":[109],"The":[110],"Role":[111],"of":[112,118,122,142,153,231],"Benefit":[113,120],"Assessment":[114],"for":[115,159,223,233],"Evidence-based":[116],"Provision":[117],"Pharmaceuticals":[119],"assessment":[121,184,203],"health":[123,135],"technologies":[124],"and":[125,205,227],"more":[126],"specifically":[127],"pharmaceuticals":[128],"can":[129],"contribute":[130],"significantly":[131],"to":[132,200,206],"a":[133,190,208],"rational":[134],"policy":[136],"Europe.":[138],"Against":[139],"the":[140,150,163,166,179,194,212,224,229],"background":[141],"positive":[143],"experiences":[144],"Germany,":[146],"based":[147],"particularly":[148],"on":[149,189],"strong":[151],"evidence":[152],"clinical":[154,171],"study":[155],"data":[156],"used":[157],"originally":[158],"marketing":[160],"authorization":[161],"applications,":[162],"developments":[164],"are":[168],"analysed:":[169],"Whereas":[170],"trials":[172],"will":[173],"be":[174],"harmonized":[175],"from":[176],"through":[178],"new":[180],"regulation,":[182],"benefit":[183,202],"is":[185,198],"still":[186],"only":[187],"coordinated":[188],"voluntary":[191],"basis":[192],"by":[193],"Network.":[196],"It":[197],"proposed":[199],"make":[201],"compulsory":[204],"apply":[207],"unified":[209],"methodology":[210],"across":[211],"whole":[213],"EU.":[214],"This":[215],"could":[216],"save":[217],"resources,":[218],"set":[219],"transparent":[220],"innovation":[221],"incentives":[222],"pharmaceutical":[225],"industry":[226],"improve":[228],"quality":[230],"provision":[232],"European":[234],"patients.":[235]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2025-10-10T00:00:00"}